Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wei Li, Jamie Katy Hu & Miaofen G Hu. (2023) CDK6: an attractive therapeutic target for T-ALL/LBL. Expert Opinion on Therapeutic Targets 27:11, pages 1087-1096.
Read now
Read now
Articles from other publishers (4)
Michael J. Austin, Foteini Kalampalika, William P. Cawthorn & Bela Patel. (2023) Turning the spotlight on bone marrow adipocytes in haematological malignancy and non‐malignant conditions. British Journal of Haematology 201:4, pages 605-619.
Crossref
Crossref
Miyoung Lee, Delaney K. Geitgey, Jamie A. G. Hamilton, Jeremy M. Boss, Christopher D. Scharer, Jennifer M. Spangle, Karmella A. Haynes & Curtis J. Henry. (2022) Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Matthew Greenwood, Toby Trahair, Rosemary Sutton, Michael Osborn, John KwanSally MappRebecca HowmanAntoinette Anazodo, Brenton WylieJames D’RozarioMark HertzbergIan IrvingDavid Yeung, Luke CoyleAmanda JagerDan EngelerNicola VennChris FramptonAndrew H. Wei, Kenneth BradstockLuciano Dalla-Pozza. (2021) An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL. Blood Advances 5:24, pages 5574-5583.
Crossref
Crossref
Anand Ashwin Patel, Joseph Heng, Emily Dworkin, Sarah Monick, Benjamin A. Derman, Adam S. DuVall, Sandeep Gurbuxani, Satyajit Kosuri, Hongtao Liu, Michael Thirman, Lucy A. Godley, Olatoyosi Odenike, Richard A. Larson & Wendy Stock. (2021) Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults. eJHaem 2:3, pages 413-420.
Crossref
Crossref